BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//ddaysoftware.com//NONSGML DDay.iCal 1.0//EN
BEGIN:VEVENT
DESCRIPTION:Discovery and Developmental Therapeutics (DDT) Program Meeting 
 - Mark M. Goodman\, PhD - "Bench to FDA Approval of Axumin (Anti-3-[18F]FA
 CBC) for Imaging Cancer" 
DTEND:20160617T100000
DTSTAMP:20261107T035245Z
DTSTART:20160617T090000
LOCATION:John H. Kauffman Auditorium (C5012\, 5th Floor Winship)
SEQUENCE:0
SUMMARY:Discovery and Developmental Therapeutics (DDT) Program Meeting - Ma
 rk M. Goodman\, PhD - "Bench to FDA Approval of Axumin (Anti-3-[18F]FACBC)
  for Imaging Cancer"
UID:d62e59ce-dbee-4b79-ae7f-4e98b07653c1
END:VEVENT
END:VCALENDAR